¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Wiskott-Aldrich Syndrome Protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • lymphoproliferative syndrome
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁõÈıº
  • middle lobe syndrome
    Áß°£¿±ÁõÈıº
  • milk-alkali syndrome
    ¿ìÀ¯¾ËÄ®¸®ÁõÈıº
  • morning glory syndrome
    ³ªÆÈ²ÉÁõÈıº
  • motor syndrome
    ¿îµ¿(ÁßÃß)ÁõÈıº
  • mucocutaneous lymph node syndrome
    Á¡¾×ÇǺθ²ÇÁÀýÁõÈıº
  • myasthenic syndrome
    ±Ù(À°)¹«·ÂÁõÈıº
  • Mallory-Weiss syndrome
    ¸»·Î¸®-¹ÙÀ̽ºÁõÈıº
  • myelodysplastic syndrome
    °ñ¼öÇü¼ºÀÌ»óÁõÈıº
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
  • myofascial pain syndrome
    ±Ù¸·ÅëÁõÁõÈıº
  • myofascial pain-dysfunction syndrome
    ±Ù¸·ÅëÁõ±â´ÉÀå¾ÖÁõÈıº
  • Marfan syndrome
    ¸¶¸£ÆÎÁõÈıº
  • maternal deprivation syndrome
    ¸ð¼º¹ÚÅ»ÁõÈıº
  • McCune-Albright syndrome
    ¸ÆÄï-¿Ãºê¶óÀÌÆ®ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • preleukemia myelodysplastic syndrome
    °ñ¼öÇü¼ºÀÌ»óÁõÈıº
  • pancoast syndrome
    ÆÇÄÚ½ºÆ®ÁõÈıº
  • peeling skin syndrome
    ÇǺιڸ®ÁõÈıº
  • phantom lover syndrome
    ȯ»ó¿¬ÀÎÁõÈıº
  • pluriglandular syndrome
    ¹µ»ùÁõÈıº, ¿©·¯»ùÁõÈıº
  • positive and negative syndrome
    ¾ç¼ºÀ½¼ºÁõÈıº
  • post-infarction syndrome
    °æ»öÈÄÁõÈıº
  • postelectric shock syndrome
    Àü±âÃæ°ÝÈÄÁõÈıº
  • postencephalitic behavioral syndrome
    ³ú¿°ÈÄÇൿÁõÈıº
  • postmenopausal syndrome
    Æó°æÈÄÁõÈıº
  • postpartum mood syndrome
    »êÈıâºÐÁõÈıº
  • premenstrual syndrome
    ¿ù°æÀüÁõÈıº
  • presbyophrenia syndrome
    ³ëÀÎÄ¡¸Å
  • prodromal radiation syndrome
    Á¶Áü¹æ»ç¼±ÁõÈıº
  • prune-belly syndrome
    ¸»¸°´ëÃßÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • Klinefelters syndrome
    Ŭ¶óÀÎÆçÅÍÁõÈıº(¡­ñøý¦ÏØ)
  • Klippel Feli syndrome
    Ŭ¸®Æç-ÆäÀÏÁõÈıº.
  • Lambert-Eaton myasthenic syndrome
    ¶÷¹öÆ®-ÀÌÆ° ±Ù¹«·ÂÁõÁõÈıº
  • Landry Guillain Barre syndrome
    ¶õµå¸®-±æ·©-¹Ù·¹ÁõÈıº.
  • Laurence Moon Biedl syndrome
    ·Î·»½º-¹®-ºñµéÁõÈıº.
  • Lesch-Nyhan syndrome
    ·¹½¬ ´ÏÇÑ ÁõÈıº
  • Leser-Trelat syndrome
    ·¹Á¦¸£ Æ®·¼¶ó ÁõÈıº
  • Lhermittes syndrome, radiation-induced
    ¹æ»ç¼±À¸·Î À¯¹ßµÈ ·¹¹ÌÅ× ÁõÈıº
  • Libman Sachs syndrome
    ¸®ºê¸¸-ÀÛ½º ÁõÈıº.
  • Loeffler s eosinophilic syndrome
    ·ÚÇ÷¯È£»ê±¸ÁõÈıº
  • Loeffler s eosinophilic syndrome
    ·ÚÇ÷¯È£»ê±¸ÁõÈıº.
  • Loefflers syndrome
    ·ÚÇ÷¯ÁõÈıº
  • Lofgrens syndrome
    ·ÚÇÁ ±×¸° ÁõÈıº
  • Marchesanis syndrome
    ¸¶¸£ÄÉ»ç´ÏÁõÈıº
  • Marcus-Gunn syndrome
    ¸¶¸£Äí½º-°ÇÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • alveolar hypoventilation syndrome
    ÆóÆ÷Àúȯ±âÁõÈıº.
  • alveolar-capillary block syndrome
    ÆóÆ÷-¸ð¼¼Ç÷°üÂ÷´ÜÁõÈıº.
  • amelo-cerebro-hypohidrotic syndrome
    ¿¡³ª¸á-´ë³ú-¶¡°ú¼ÒÁõÈıº
  • amnestic syndrome
    °Ç¸ÁÁõÈıº(¡­ñøý¦ÏØ).
  • amniotic band syndrome
    ¾ç¸·´ëÁõÈıº(¡­Óáñøý¦ÏØ)
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ( ³²¼ºÈ£¸£¸ó) ºÒ°¨¼º ÁõÈıº(ÝÕÊïàõ ñøý¦ÏØ)
  • androgen-resistance syndrome
    ³²¼ºÈ£¸£¸ó ³»¼º(ÀúÇ×)ÁõÈıº?
  • anginal syndrome
    Çù½ÉÁõÁõÈıº (¡­ñøñøý¦ÏØ).
  • angioosteohypertrophy syndrome
    Ç÷°ü °ñºñÈÄ ÁõÈıº(úìη ÍéÝþý§ ñøý¦ÏØ)
  • anorectal syndrome
    Ç×¹®Á÷ÀåÁõÈıº(ùýÚ¦òÁ ñøý¦ÏØ).
  • anorectal syndrome
    Ç×¹®Á÷ÀåÁõÈıº(Ç×¹®Á÷ÀåÁõÈıº).
  • anterior chamber cleavage syndrome
    Àü¹æ(°¢)ºÐ¸®ºÎÀüÁõÈıº
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ôÃѵ¿¸Æ Æó¼âÁõÈıº.
  • anterior cornual syndrome
    Àü°¢ÁõÈıº(îñÊÇñøý¦ÏØ).
  • anterior scalene syndrome
    Àü»ç°¢±ÙÁõÈıº(îñÞØÊÇÐÉñøý¦ÏØ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • unstable protein
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • unwinding protein
    °¨±èÇ®±â ´Ü¹éÁú (Ó±ÛÜòõ)
  • U protein
    U ´Ü¹éÁú (Ó±ÛÜòõ)
  • yellow protein reaction
    Ȳ»ö ´Ü¹éÁú(üÜßäÓ±ÛÜòõ) ¹ÝÀÀ (Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
PP diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa...
PPD packs per day; paraphenylenediamine; percussion and postural drainage; permanent partial disability;...
PPP pain perception profile; palatopharyngoplasty; palmoplantar pustulosis; pentose phosphate pathway; p...
PSP pancreatic spasmolytic peptide; paralytic shellfish poisoning; parathyroid secretory protein; period...
PTP pancreatic thread protein; percutaneous transhepatic portography; physical treatment planning; poste...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
CS Cowden syndrome
CS Cushing syndrome
CVS Cyclic vomiting syndrome
DSS Dejerine-Sottas Syndrome
DSPS Delayed Sleep Phase Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hepatoovarian syndrome
    °£ ³­¼Ò ÁõÈıº
  • hepatorenal syndrome
    °£ ½Å ÁõÈıº
    °£ Áõ»ó°ú ÇÔ²² ¿äÁß¿¡ ´Ü¹é, ¿øÁÖ°¡ ³ªÅ¸³ª°í, ¿äÀÇ ºÐ·®ÀÌ °¨¼ÒÇÏ´Â »óÅÂ. °£°ú ½ÅÀåÀÌ µ¿½Ã¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â ÀÏÀº ÀÓ»ó¿¡¼­ ¿¾³¯ºÎÅÍ ÀÎÁ¤µÇ¾î ¿Ô´Ù. ±× ÀÌÀ¯´Â, ù° ¼¼±ÕÀÇ °¨¿°À¸·Î ÀÎÇÑ °£ ½Å¿°, µÑ° °£ Áßµ¶, ¼Â° °£ °æº¯, ³Ý° ¹ÙÀÌ·¯½º¼ºÀ¸·Î ÀÎÇÑ °Í µîÀÌ ÀÖ´Ù.
  • heritable melanoma syndrome
    À¯Àü¼º Èæ»öÁ¾ ÁõÈıº
  • histiocytosis syndrome
    Á¶Á÷±¸Áõ ÁõÈıº
  • Holt Oram syndrome
    ȦƮ-¿À¶÷ ÁõÈıº
  • Horner's syndrome
    È£³Ê ÁõÈıº, Horner ÁõÈıº
    ÆíÃø¼º Ãൿ ¼öÁõ, ±×¸®°í ¾È¸é Å»¼öÁõÀÌ Æ¯Â¡ÀÎ ½Å°æ¼º »óÅ·μ­ º¸Åë °æºÎ ±³°¨¼º ¸¶ºñ·ÎºÎÅÍ ¹ß»ýµÈ´Ù.
  • Horton's syndrome
    Horton ÁõÈıº
    cluster headache¸¦ º¸½Ã¿À.
  • Hurler-Scheie syndrome
    Çæ·¯-»þÀÌ¿¡ ÁõÈıº
  • Hutchinson's syndrome
    ÇãÄ£½¼ ÁõÈıº
    °£Áú °¢¸·¿°, ¹Ì·Î Áúȯ, ÇãÄ£½¼ Ä¡¾ÆÀÇ º¹ÇÕÀ¸·Î ¼±Ãµ ¸Åµ¶¿¡¼­ º¼ ¼ö ÀÖ´Ù. ¼±Ãµ¼º ¸Åµ¶ÀÇ Áõ»óÀ¸·Î ÇãÄ£½¼ 3ÁÖÁõÀ¸·Î Áø´ÜÇÒ ¼ö ÀÖ´Ù. ¸Åµ¶Àº 1Â÷, 2Â÷, 3Â÷ÀÇ ´Ü°è¸¦ º¸À̸ç À¯Àü¼ºÀ» ¶ì°í ÀÖ´Ù.
  • hyperimmunoglobulin E syndrome
    °ú¸é¿ª ±Û·ÎºÒ¸° E ÁõÈıº
  • hyperkinetic heart syndrome
    °ú¿îµ¿¼º ½ÉÁõÈÄ, °ú¿îµ¿¼º ½ÉÁõÈıº
  • hypermobility syndrome
    °ú¿îµ¿ ÁõÈıº
  • hyperstimulation syndrome
    °úÀÚ±Ø ÁõÈıº
  • hyperviscosity syndrome
    °íÁ¡µµ ÁõÈıº
    °ñ¼öÁ¾ ´Ü¹éÀÌ °ú´ÙÇÏ°Ô »ý¼ºµÈ °ÍÀÌ ÀÀÁýµÇ¾î ³ªÅ¸³­´Ù. ´Ù¹ß¼º °ñ¼öÁ¾ ȯÀÚÀÇ ¾à 7%¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • hypogenetic lung syndrome
    Àú¹ß»ý Æó ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
protein c inhibitor <chemical> A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and able to inhibit activated protein c, thrombin, kallikrein, and other serine proteinases.
Pharmacological action: serine proteinase inhibitors.
(12 Dec 1998)
protein conformation The characteristic 3-dimensional shape of a protein, imposed upon it by the secondary and tertiary structure of the peptide chain. This stage in the structure of a protein describes the highest level of organization in overall structure assumed by multimeric proteins (aggregates of more than one polypeptide chain). This is the fourth folding level of protein building.
(12 Dec 1998)
protein crystallization This is an essential process in determining a protein's three-dimensional structure, and hence in using that information to design drugs.
(14 Nov 1997)
protein-D-aspartate methyltransferase <enzyme> For protein carboxymethylases consider also protein o-methyltransferase
Registry number: EC 2.1.1.77
Synonym: d-aspartyl-l-isoaspartyl methyltransferase, protein d-aspartate-l-isoaspartate methyltransferase, protein l-isoaspartate o-methyltransferase, protein-beta-aspartate methyltransferase, protein-l-isoaspartate methyltransferase, protein l-isoaspartyl methyltransferase, isoaspartyl-aspartyl protein methyltransferase, protein-d-asp methyltransferase, l-isoaspartyl protein carboxymethyltransferase, pcm gene product, pcmt1 gene product
(26 Jun 1999)
protein deficiency A nutritional condition produced by a deficiency of proteins in the diet, characterised by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization).
(12 Dec 1998)
protein disulfide-isomerase <enzyme> An enzyme that catalyses the rearrangement of disulfide bonds within proteins during folding. It is a monomer identical to one of the subunits of procollagen-proline dioxygenase.
Chemical name: Protein disulfide-isomerase
Registry number: EC 5.3.4.1
(12 Dec 1998)
protein disulfide reductase (glutathione) <enzyme> An enzyme that catalyses the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates.
Chemical name: Glutathione:protein-disulfide oxidoreductase
Registry number: EC 1.8.4.2
(12 Dec 1998)
protein-energy malnutrition The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses.
(12 Dec 1998)
protein engineering Normally means the use of recombinant DNA technology to produce proteins with desired modifications in the primary sequence.
See: site specific mutagenesis.
(18 Nov 1997)
protein factor The factor (6.25) by which the nitrogen content of a protein is multiplied to give the amount of protein.
(05 Mar 2000)
protein fever Fever produced by the injection of foreign protein, such as milk.
(05 Mar 2000)
protein folding A rapid biochemical reaction involved in the formation of proteins. It begins even before a protein has been completely synthesised and proceeds through discrete intermediates (primary, secondary, and tertiary structures) before the final structure (quaternary structure) is developed.
(12 Dec 1998)
protein G Protein from Group C Streptococci that binds the Fc portion of IgG. Is less species specific than Protein A.
(18 Nov 1997)
protein geranylgeranyltransferase <enzyme> Involved in protein isoprenylation; transfers geranylgeranyl group to cys fourth from the c-terminal of GTP-binding proteins; amino acid sequence of beta subunit of ggtase-i known; genbank l24116; see also rab, ras, and rhoa p21 geranylgeranyl- transferases and component a, rab geranylgeranyltransferase
Registry number: EC 2.5.1.-
Synonym: protein ggtase, geranylgeranyltransferase type-i, ggtase-i, geranylgeranyl-protein transferase type 1
(26 Jun 1999)
protein-glutamine gamma-glutamyltransferase <enzyme> An enzyme that catalyses the reaction of protein glutamine and an alkylamine to yield protein n(5)-alkylglutamine and ammonia. The gamma-carboxamide groups of peptide-bound glutamine residues act as acyl donors, and the 6-amino groups of protein- and peptide-bound lysine residues act as acceptors, to give intra- and inter-molecular n(6)-(5-glutamyl)lysine crosslinks. In the epidermis these cross-linked proteins are involved in the formation of the cornified envelope of the stratum corneum cells. In the plasma, the transglutaminase is called factor xiiia, the activated form of factor xiii. The crosslinking results in the stabilization of the fibrin clot.
Pharmacological action: coagulants.
Chemical name: Protein-glutamine:amine gamma-glutamyltransferase
Registry number: EC 2.3.2.13
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á